Skip to Content
 
Center for International Blood and Marrow Transplant Research

LY18-01b

Main Content

Outcomes in B cell non-Hodgkin lymphoma patients who underwent autologous stem cell transplantation following rituximab containing conditioning regimens in partial remission.

Study #: LY18-01b

Study Status: Published

Presentation(s)

2020, ASCO (Oral)

Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?

Citation

Shah NN, Ahn KW, Litovich C, He Y, Sauter C, Fenske TS, Hamadani M.

Blood. 2021, Mar 22: 137(10): 137(10):1416-1423. doi: 10.1182/blood.2020007939. Epub 2020, Oct 29. PMCID:PMC7955408.

PubMed

PMID: 33120429

Abstract